Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics, Alticor Expand Genetic Test License Agreement

NEW YORK (GenomeWeb News) – Interleukin Genetics said today it has expanded an agreement with Alticor division Access Business Group giving both companies increased access to genetic tests that the two companies have developed together under research programs.
Under the agreement, the existing license that ABG holds to Interleukin Genetics’ intellectual property will become non-exclusive, the company said. Interleukin Genetics will gain the right to brand, market, sell, and distribute all genetic tests developed using existing and future intellectual property.
ABG also will continue to distribute the Heart Health and General Nutrition genetic tests under the Gensona brand name, and Interleukin Genetics will continue to have exclusive ownership of all of the inventions relating to genetic tests stemming from the two companies’ programs.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.